Please Wait...

Tanja Schubert

Translation skills

Main profile

Tanja Schubert, Ph.D.
VP & General Manager Biochemical Markers

Dr. Schubert leads the Molecular Marker practice at Bioclinica and is responsible for all operational and organizational activities, overseeing service quality, study management, process improvements and regulatory compliance. She is actively engaged in business development and client discussions advising in implementing biochemical markers in clinical trials. Dr. Schubert oversees the laboratory activities and serves as accredited Laboratory Director for the College of American Pathologists. Prior to her current position, Dr. Schubert joined legacy Synarc Laboratory in 2006 as Head of the Project Management Department and was responsible for all operational aspects of a clinical trial management.

Dr. Schubert is a trained Pharmacist and received a PhD in Natural Sciences from the Ludwig-Maximilians-Universität in Munich, Germany.

Blogs

CSF biomarkers & Alzheimer's Disease

The Importance of Early Diagnosis for AD Last month, scientists, clinicians, drug sponsors, and regulators gathered in our nation's capital at the annual Alzheimer's Association International Conference (AAIC) to share recent advances in AD research and clinical drug development.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Dr Joby John chairing a panel discussion tomorrow 8am at #DIA2019 on ways to improve connectedness of clinical data… https://t.co/BPzi1geKsv
Bioclinica (14 hours ago)
Meet the Bioclinica team at DIA Booth 1831. #DIA2019 https://t.co/pvvdiqJz32 https://t.co/tx4PLDIrMm
Bioclinica (16 hours ago)
We’re at #DIA2019. Visit us at booth #1831 to learn more about our rapidly growing services and meet face to face… https://t.co/rK7V1Aclov
Bioclinica (19 hours ago)
Learn about When EDC is not enough: Automating multi-country data collection and complete workflows at #DIA2019! Ja… https://t.co/zJfytNpz82
Bioclinica (1 week ago)
In San Diego for #DIA2019? Visit us at booth #1831 and meet face to face with our team to learn more about our rapi… https://t.co/T4U4oNXlxo
Bioclinica (2 weeks ago)
We're celebrating International #NASH Day to help raise awareness about non-alcoholic steatohepatitis & fatty liver… https://t.co/16PfGbzeaS
Bioclinica (2 weeks ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box